Copyright © 2018 Claristock. All Right Reserved
Total Mark
89
Above 70 is preferred
Stock Analysis
| Growth Potential | 76 | |
|---|---|---|
| Profitability | 98 | |
| Financial Strength | 100 | |
| Q2 2018 Result | 75 | |
| Q1 2017 Result | 86 | |
| Result 2017 | 96 |
Growth Estimate
| 18 Estimate | 19 Estimate | Estimate | |
|---|---|---|---|
| Revenue Growth (%) | 18 | 12 | ... |
| EPS Growth (%) | 20 | 23 | ... |
| ROE (%) | 60.6 | 59.9 | ... |
| P/E (times) | ... | ... | ... |
Market Analysis
| Market Sentiment | 67 | |
|---|---|---|
| Relative Valuation | 98 | |
| Being a Value Stock | 75 | |
| Absolute Valuation | 12 |
For more detailed information about Celgene Corporation, please go to Yahoo Finance